NASDAQ:HEXOHEXO Stock Price, Forecast & News

HEXO's stock was trading at $0.9376 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, HEXO stock has decreased by 32.2% and is now trading at $0.6357. View which stocks have been most impacted by Coronavirus.

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HEXO in the last year. There are currently 10 sell ratings, 7 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for HEXO.

HEXO is scheduled to release its next quarterly earnings announcement on Thursday, June 11th 2020. View our earnings forecast for HEXO.

HEXO Corp. (NASDAQ:HEXO) announced its quarterly earnings data on Monday, March, 30th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.06) by $0.02. The business had revenue of $12.89 million for the quarter, compared to analyst estimates of $12.21 million. View HEXO's earnings history.

18 brokerages have issued 12 month target prices for HEXO's shares. Their forecasts range from $1.00 to $4.00. On average, they anticipate HEXO's stock price to reach $1.70 in the next twelve months. This suggests a possible upside of 167.0% from the stock's current price. View analysts' price targets for HEXO.

Press coverage about HEXO stock has trended somewhat negative on Friday, InfoTrie reports. The research group ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. HEXO earned a coverage optimism score of -1.6 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news aboutHEXO.

Some companies that are related to HEXO include HLS Therapeutics (HLS), OrganiGram (OGI), Next Science (NXS), ICC Labs (ICC), Amryt Pharma (AMYT), Benchmark (BMK), Green Organic Dutchman (TGOD), WeedMD (WMD), Probiotec (PBP), ESSA Pharma (EPI), CannTrust (TRST), Supreme Cannabis (FIRE), Shield Therapeutics (STX), Althea Group (AGH) and Delta 9 Cannabis (NINE). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other HEXO investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), Aphria (APHA), OrganiGram (OGI), Aurora Cannabis (ACB), Tilray (TLRY), Charlotte's Web (CWBHF), NVIDIA (NVDA) and Alibaba Group (BABA).

HEXO trades on the NASDAQ under the ticker symbol "HEXO."

HEXO's stock is owned by a number of retail and institutional investors. Top institutional shareholders include ETF Managers Group LLC (6.02%), Morgan Stanley (0.72%), Public Sector Pension Investment Board (0.21%), AdvisorShares Investments LLC (0.04%), CLARET ASSET MANAGEMENT Corp (0.05%) and Toronto Dominion Bank (0.02%).

HEXO stock was sold by a variety of institutional investors in the last quarter, including AdvisorShares Investments LLC, Jane Street Group LLC, Sigma Planning Corp, and Toronto Dominion Bank.

HEXO stock was purchased by a variety of institutional investors in the last quarter, including ETF Managers Group LLC, Morgan Stanley, Public Sector Pension Investment Board, CLARET ASSET MANAGEMENT Corp, UBS Group AG, and Advisor Group Holdings Inc..

Shares of HEXO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of HEXO stock can currently be purchased for approximately $0.64.

HEXO has a market capitalization of $259.27 million.

The official website for HEXO is hexo.com.

The company can be reached via phone at 844-406-1852.